2616 fundamentals
CSTONE PHARMACEUTICALS earnings per share and revenue
2616 earnings per share for the last semiannual are -0.09 HKD whereas the estimation was -0.03 HKD which accounts for -166.67% surprise. Company revenue for the same period amounts to 162.89 M HKD despite the estimated figure of 334.88 M HKD. Estimated earnings per share for the next semiannual are -0.11 HKD, and revenue is expected to reach 115.92 M HKD. Also watch annual changes over time to get a bigger picture of 2616 earnings per share and revenue dynamics.
Next report date—
Report period—
EPS estimate—
Revenue estimate—
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise